Javascript must be enabled to continue!
Comparative effects of combinations of metformin, omega-3 and omega-6 oil in the treatment of alloxan-induced diabetic rats
View through CrossRef
Emerging evidence suggests beneficial effects of omega fatty acids on diabetic complications. This study was designed to investigate the impact of Omega-3 and Omega-6 oil in the management of oxidative stress associated with complications in diabetes in alloxan induced diabetic rats. Experimental rats used in this study were grouped into four as non-diabetics and untreated, alloxan induced diabetic group, alloxan induced and treated with Metformin, lloxan induced and administered Metformin + Omega-3, alloxan induced and administered Metformin + Omega-6 oil. Effect of Metformin + Omega-3 and Metformin + Omega-6 on plasma glucose were also evaluated. Serum lipid profile before and after treatment, lipid peroxidation activity of malondialdehyde, and antioxidant enzyme activity of superoxide dismutase were assessed. Histological examination of pancreas and liver biopsy were also carried out. The results showed that fasting blood glucose (FBS) levels in day 1, day 7, day 14 and day 21 were significantly (p<0.05) lower than in the other groups. Superoxide Dismutase (SOD) activity was significantly (P>0.05) higher in Metformin + Omega-6 group when compared with diabetic control group at P= 0.011. Malondialdehyde (MDA) activity studied among groups was significantly lower (P< 0.05) in Metformin + Omega-3 group and Metformin + Omega-6 group when compared with the diabetic control group at P =0.008 and 0.016 respectively. There was statistically significant mean weight reduction (P<0.05) post intervention for all the alloxan-exposed rats. Metformin + Omega-6 group liver photomicrograph showed marked regenerated hepatocytes with normal histologic architecture. Metformin + Omega-3 group and Metformin + Omega-6 group photomicrograph revealed moderate regeneration of β cells of the Islets of Langerhans. The study demonstrates that treatment with Metformin and Omega-3 / Omega-6 oil intervention in diabetic rats significantly ameliorates hyperglycemia, exhibits pancreatic protective effects and reduces lipid peroxidation activity of MDA.
Title: Comparative effects of combinations of metformin, omega-3 and omega-6 oil in the treatment of alloxan-induced diabetic rats
Description:
Emerging evidence suggests beneficial effects of omega fatty acids on diabetic complications.
This study was designed to investigate the impact of Omega-3 and Omega-6 oil in the management of oxidative stress associated with complications in diabetes in alloxan induced diabetic rats.
Experimental rats used in this study were grouped into four as non-diabetics and untreated, alloxan induced diabetic group, alloxan induced and treated with Metformin, lloxan induced and administered Metformin + Omega-3, alloxan induced and administered Metformin + Omega-6 oil.
Effect of Metformin + Omega-3 and Metformin + Omega-6 on plasma glucose were also evaluated.
Serum lipid profile before and after treatment, lipid peroxidation activity of malondialdehyde, and antioxidant enzyme activity of superoxide dismutase were assessed.
Histological examination of pancreas and liver biopsy were also carried out.
The results showed that fasting blood glucose (FBS) levels in day 1, day 7, day 14 and day 21 were significantly (p<0.
05) lower than in the other groups.
Superoxide Dismutase (SOD) activity was significantly (P>0.
05) higher in Metformin + Omega-6 group when compared with diabetic control group at P= 0.
011.
Malondialdehyde (MDA) activity studied among groups was significantly lower (P< 0.
05) in Metformin + Omega-3 group and Metformin + Omega-6 group when compared with the diabetic control group at P =0.
008 and 0.
016 respectively.
There was statistically significant mean weight reduction (P<0.
05) post intervention for all the alloxan-exposed rats.
Metformin + Omega-6 group liver photomicrograph showed marked regenerated hepatocytes with normal histologic architecture.
Metformin + Omega-3 group and Metformin + Omega-6 group photomicrograph revealed moderate regeneration of β cells of the Islets of Langerhans.
The study demonstrates that treatment with Metformin and Omega-3 / Omega-6 oil intervention in diabetic rats significantly ameliorates hyperglycemia, exhibits pancreatic protective effects and reduces lipid peroxidation activity of MDA.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
<p>Νίκος Οικονομίδης</...
DYNAMICS OF CHANGES IN THE INDICES OF LIPID PEROXIDATION AND ANTIOXIDANT SYSTEM IN RATS WITH ALLOXAN DIABETES, MODELED ON THE BACKGROUND OF THE PRELIMINARY TOXICITY OF HEAVY METAL SALTS
DYNAMICS OF CHANGES IN THE INDICES OF LIPID PEROXIDATION AND ANTIOXIDANT SYSTEM IN RATS WITH ALLOXAN DIABETES, MODELED ON THE BACKGROUND OF THE PRELIMINARY TOXICITY OF HEAVY METAL SALTS
Aim: to study the processes of lipid peroxidation and the antioxidant defense system in rats with alloxan-induced diabetes against the background of isolated and combined exposure ...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Efficacy and Safety of Fennel in Alloxan-induced Male Diabetic Rats
Efficacy and Safety of Fennel in Alloxan-induced Male Diabetic Rats
Background & objective: Diabetes mellitus is a growing global health concern characterized by chronic hyperglycemia and associated complications, including hepatotoxicity. Tra...
P–229 Oxidative stress and Metformin; an in-vitro study on serum and primary human granulosa cell cultures
P–229 Oxidative stress and Metformin; an in-vitro study on serum and primary human granulosa cell cultures
Abstract
Study question
What is the effect of administration of Metformin on the oxidative stress (OS) levels in serum and prima...

